Form 4: NeuroOne Medical Technologies CEO David Rosa Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
NeuroOne Medical Technologies CEO David Rosa disposed of 2,239 shares of common stock on October 31, 2024, to cover tax obligations.
Summary
- On October 31, 2024, David A. Rosa, CEO and President of NeuroOne Medical Technologies Corp, disposed of 2,239 shares of common stock.
- The transaction was executed at a price of $0.97 per share.
- This disposal was to cover tax obligations.
- Following the transaction, Rosa directly owns 1,144,247 shares of NeuroOne Medical Technologies Corp.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a transaction by an insider. The disposal of shares to cover tax obligations is a neutral event.
Industry Context
This is a routine disclosure related to insider transactions. It is common for executives to sell shares to cover tax obligations arising from stock-based compensation.
Key Dates
| Date | Description |
|---|---|
| 10/31/2024 | Date of transaction: David Rosa disposed of shares. |
| 11/01/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.